GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 213 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $610,000 | -7.7% | 12,563 | 0.0% | 0.02% | -12.5% |
Q2 2019 | $661,000 | -13.3% | 12,563 | -12.7% | 0.02% | -27.3% |
Q1 2019 | $762,000 | -24.7% | 14,383 | -41.6% | 0.03% | -45.9% |
Q4 2018 | $1,012,000 | +509.6% | 24,644 | +569.1% | 0.06% | +662.5% |
Q2 2018 | $166,000 | – | 3,683 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
Grace Capital | 131,549 | $5,697,000 | 3.60% |
Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |